Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma

Clinical trial NCT04701918 · COMPLETED

Trial details

NCT number: NCT04701918
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Urothelial Carcinoma Bladder Cancer

Start date: 2021-06-04
Primary completion: 2025-12-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.